Top Clinical Trials companies in United Kingdom by Free Cash Flow Per Share

This ranking features the top 33 Clinical Trials companies in United Kingdom ranked by Free Cash Flow Per Share, averaging a Free Cash Flow Per Share of USD -0.51, for February 06, 2025.
#
Name
Free Cash Flow Per Share
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 4.20
Dec. 31, 2023 USD 139.13 1.09%

United Kingdom

2
USD 0.74
Dec. 31, 2023 USD 49.95 -1.36%

United Kingdom

3
USD 0.02
Dec. 31, 2023 USD 0.23 -1.64%

United Kingdom

4
USD -0.00
Dec. 31, 2023 USD 0.32 1.02%

United Kingdom

5
USD -0.01
June 30, 2024 USD 0.01 -16.48%

United Kingdom

6
USD -0.02
Dec. 31, 2023 USD 0.16 0.22%

United Kingdom

7
USD -0.02
Dec. 31, 2023 USD 0.03 -13.02%

United Kingdom

8
USD -0.02
April 30, 2024 USD 0.11 -2.49%

United Kingdom

9
USD -0.03
Dec. 31, 2023 USD 3.01 2.73%

United Kingdom

10
USD -0.04
Sept. 30, 2023 USD 0.15 -5.79%

United Kingdom

11
USD -0.04
Dec. 31, 2023 USD 0.05 0.22%

United Kingdom

12
USD -0.05
Dec. 31, 2023 USD 32.88 0.83%

United Kingdom

13
USD -0.05
Dec. 31, 2023 USD 0.03 15.64%

United Kingdom

14
USD -0.06
June 30, 2024 USD 0.24 0.22%

United Kingdom

15
USD -0.07
Dec. 31, 2023 USD 0.04 18.86%

United Kingdom

16
USD -0.08
Dec. 31, 2023 USD 0.59 3.49%

United Kingdom

17
USD -0.09
Dec. 31, 2023 USD 0.22 -0.34%

United Kingdom

18
USD -0.10
Dec. 31, 2023 USD 0.05 0.22%

United Kingdom

19
USD -0.12
Aug. 31, 2023 USD 0.11 -15.01%

United Kingdom

20
USD -0.13
Dec. 31, 2023 USD 0.26 0.22%

United Kingdom

21
USD -0.18
Dec. 31, 2023 USD 0.57 0.22%

United Kingdom

22
USD -0.25
Dec. 31, 2023 USD 0.68 -3.32%

United Kingdom

23
USD -0.32
March 31, 2024 USD 1.06 -3.64%

United Kingdom

24
USD -0.63
Dec. 31, 2023 USD 57.30 0.10%

United Kingdom

25
USD -0.90
Dec. 31, 2023 USD 2.21 0.46%

United Kingdom

26
USD -0.98
March 31, 2024 USD 11.13 -2.11%

United Kingdom

27
USD -1.24
Dec. 31, 2023 USD 1.13 0.89%

United Kingdom

28
USD -1.35
Dec. 31, 2023 USD 5.33 1.52%

United Kingdom

29
USD -1.67
Dec. 31, 2023 USD 16.92 0.06%

United Kingdom

30
USD -1.71
Dec. 31, 2023 USD 1.16 -5.69%

United Kingdom

31
USD -1.79
Dec. 31, 2023 USD 13.39 4.86%

United Kingdom

32
USD -1.91
Dec. 31, 2023 USD 4.31 3.36%

United Kingdom

33
USD -3.36
Dec. 31, 2023 USD 1.09 -19.26%

United Kingdom

Frequently Asked Questions
  • Which Clinical Trials company in United Kingdom has the highest Free Cash Flow Per Share ?

    The Clinical Trials company in United Kingdom with the highest Free Cash Flow Per Share is AstraZeneca PLC (LSE: AZN.L) at USD 4.20.

  • Which Clinical Trials company in United Kingdom has the lowest Free Cash Flow Per Share ?

    The Clinical Trials company in United Kingdom with the lowest Free Cash Flow Per Share is Akari Therapeutics, Plc (NasdaqCM: AKTX) at USD -3.36.

SV Wall Street